A detailed history of Spearhead Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Spearhead Capital Advisors, LLC holds 4,417 shares of AMGN stock, worth $1.39 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
4,417
Previous 37,894 88.34%
Holding current value
$1.39 Million
Previous $9.22 Million 89.2%
% of portfolio
1.08%
Previous 1.38%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

SELL
$224.46 - $253.15 $7.51 Million - $8.47 Million
-33,477 Reduced 88.34%
4,417 $996,000
Q2 2022

Aug 10, 2022

SELL
$230.71 - $256.74 $1.81 Million - $2.01 Million
-7,833 Reduced 17.13%
37,894 $9.22 Million
Q1 2022

Apr 28, 2022

BUY
$219.27 - $242.57 $551,244 - $609,820
2,514 Added 5.82%
45,727 $11.1 Million
Q4 2021

Jan 25, 2022

BUY
$198.88 - $227.6 $246,213 - $281,768
1,238 Added 2.95%
43,213 $9.72 Million
Q3 2021

Oct 27, 2021

BUY
$212.27 - $248.7 $1.31 Million - $1.53 Million
6,160 Added 17.2%
41,975 $8.93 Million
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $145,053 - $160,925
621 Added 1.76%
35,815 $8.73 Million
Q1 2021

Apr 28, 2021

BUY
$221.91 - $258.6 $1.82 Million - $2.12 Million
8,212 Added 30.44%
35,194 $8.76 Million
Q4 2020

Feb 02, 2021

BUY
$216.38 - $257.67 $174,835 - $208,197
808 Added 3.09%
26,982 $6.2 Million
Q3 2020

Oct 16, 2020

BUY
$234.65 - $260.95 $465,780 - $517,985
1,985 Added 8.21%
26,174 $6.65 Million
Q2 2020

Jul 16, 2020

SELL
$197.81 - $242.74 $148,357 - $182,055
-750 Reduced 3.01%
24,189 $5.71 Million
Q1 2020

Apr 17, 2020

BUY
$182.24 - $241.7 $403,661 - $535,365
2,215 Added 9.75%
24,939 $5.06 Million
Q4 2019

Feb 06, 2020

BUY
$189.21 - $243.2 $232,160 - $298,406
1,227 Added 5.71%
22,724 $5.48 Million
Q3 2019

Oct 21, 2019

BUY
$174.11 - $208.62 $3,482 - $4,172
20 Added 0.09%
21,497 $4.16 Million
Q2 2019

Jul 17, 2019

BUY
$166.7 - $195.41 $298,059 - $349,393
1,788 Added 9.08%
21,477 $3.96 Million
Q1 2019

Apr 23, 2019

BUY
$180.87 - $203.88 $142,525 - $160,657
788 Added 4.17%
19,689 $3.74 Million
Q4 2018

Feb 07, 2019

SELL
$178.4 - $208.25 $77,604 - $90,588
-435 Reduced 2.25%
18,901 $3.68 Million
Q3 2018

Oct 11, 2018

BUY
$185.29 - $208.89 $54,660 - $61,622
295 Added 1.55%
19,336 $3.98 Million
Q2 2018

Jul 25, 2018

BUY
$166.05 - $186.51 $183,983 - $206,653
1,108 Added 6.18%
19,041 $3.52 Million
Q1 2018

Apr 12, 2018

BUY
$169.43 - $198.0 $2.03 Million - $2.37 Million
11,994 Added 201.95%
17,933 $3.06 Million
Q4 2017

Jan 23, 2018

BUY
$168.79 - $188.59 $1 Million - $1.12 Million
5,939
5,939 $1.03 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Spearhead Capital Advisors, LLC Portfolio

Follow Spearhead Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.